Schedule 13G ownership disclosure
Beam Therapeutics Inc
Security class unavailable · CUSIP: 07373V105
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,966,403
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-001423
- Form type
- SC 13G
- Filer
- Beam Therapeutics Inc.
- CIK
- CIK 1745999
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership